Evidence map›Paper›PMID 39453255›Full record

ReviewTropical medicine and infectious disease2024

Artificial Intelligence in Infectious Disease Clinical Practice: An Overview of Gaps, Opportunities, and Limitations.

Andreas Sarantopoulos, Christina Mastori Kourmpani, Atshaya Lily Yokarasa, Chiedza Makamanzi, Polyna Antoniou, Nikolaos Spernovasilis, Constantinos Tsioutis

Abstract readReview
In one paragraph

Review in Tropical medicine and infectious disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Integrating AI into infection control: Evaluating the accuracy and consistency of four leading platforms across three regions.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andreas SarantopoulosSchool of Medicine, European University of Cyprus, 2404 Nicosia, Cyprus.ORCID 0009-0001-1390-6472
Christina Mastori KourmpaniSchool of Medicine, European University of Cyprus, 2404 Nicosia, Cyprus.ORCID 0009-0008-8925-829X
Atshaya Lily YokarasaSchool of Medicine, European University of Cyprus, 2404 Nicosia, Cyprus.
Chiedza MakamanziSchool of Medicine, European University of Cyprus, 2404 Nicosia, Cyprus.
Polyna AntoniouSchool of Medicine, European University of Cyprus, 2404 Nicosia, Cyprus.
Nikolaos SpernovasilisDepartment of Infectious Diseases, German Oncology Centre, 4108 Limassol, Cyprus.ORCID 0000-0002-6981-8535
Constantinos TsioutisSchool of Medicine, European University of Cyprus, 2404 Nicosia, Cyprus.ORCID 0000-0002-7865-8529

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The integration of artificial intelligence (AI) in clinical medicine marks a revolutionary shift, enhancing diagnostic accuracy, therapeutic efficacy, and overall healthcare delivery. This review explores the current uses, benefits, limitations, and future applications of AI in infectious diseases, highlighting its specific applications in diagnostics, clinical decision making, and personalized medicine. The transformative potential of AI in infectious diseases is emphasized, addressing gaps in rapid and accurate disease diagnosis, surveillance, outbreak detection and management, and treatment optimization. Despite these advancements, significant limitations and challenges exist, including data privacy concerns, potential biases, and ethical dilemmas. The article underscores the need for stringent regulatory frameworks and inclusive databases to ensure equitable, ethical, and effective AI utilization in the field of clinical and laboratory infectious diseases.

Indexed as

artificial intelligenceclinical medicinedata privacydeep learningdiagnosisethicslimitationsmachine learningpersonalized medicineresearchtherapeutics

Identifiers

PMID39453255
PMCPMC11511260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.